indospicine/colorectal neoplasms

Arginine-deprivation therapy is a rapidly developing metabolic anticancer approach. To overcome the resistance of some cancer cells to this monotherapy, rationally designed combination modalities are needed. In this report we evaluated for the first time indospicine, an arginine analogue of